Skip to main content
Log in

Adding third HAART regimen of benefit in Africa

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Bendavid E, Wood R, Katzenstein DA, Bayoumi AM, Owens DK.Expanding antiretroviral options in resource-limited settings - a cost-effectiveness analysis. JAIDS 52: 106-113, No. 1, 1 Sep 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adding third HAART regimen of benefit in Africa. Pharmacoecon. Outcomes News 588, 7 (2009). https://doi.org/10.2165/00151234-200905880-00016

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905880-00016

Keywords

Navigation